Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories

Written By Krista Verlis

Moynihan, R., Lai, A., Jarvis, H., Duggan, G., Goodrick, S., Beller, E., & Bero, L. (2019). Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. BMJ open, 9(2), e025864. https://doi.org/10.1136/bmjopen-2018-025864

https://bmjopen.bmj.com/content/9/2/e025864#new_tab

Krista Verlis
Previous

Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study
Next

Citizens’ juries can bring public voices on overdiagnosis into policy making